Trial ID: | L0430 |
Source ID: | EUCTR2020-000220-19-AT
|
Associated Drug: |
Liraglutide
|
Title: |
Comparing effects of weight loss by Liraglutide 3.0 mg with conventional liver fasting in non-alcoholic fatty liver disease before bariatric surgery - Weight loss under Liraglutide 3.0mg
|
Acronym: |
--
|
Status: |
Authorised
|
Study Results: |
No Results Available
|
Results: |
--
|
Conditions: |
Obesity and NAFLD can increase the risk and complexity of bariatric surgery up to 20%. Reducing the weight and liver size before bariatric surgery improves the operation area and reduces complications after the procedure.;Therapeutic area: Body processes
|
Interventions: |
<br>Trade Name: Saxenda<br>Pharmaceutical Form: Solution for injection<br>INN or Proposed INN: LIRAGLUTIDE<br>CAS Number: 204656-20-2<br>Concentration unit: mg/ml milligram(s)/millilitre<br>Concentration type: equal<br>Concentration number: 6-<br><br>
|
Outcome Measures: |
Main Objective: weight loss before bariatric surgery ;Secondary Objective: liver size reduction;Primary end point(s): weight loss before bariatric surgery ;Timepoint(s) of evaluation of this end point: after 12 weeks Secondary end point(s): liver size reduction;Timepoint(s) of evaluation of this end point: after 12 weeks
|
Sponsor/Collaborators: |
Verein zur F??rderung von Wissenschaft und Forschung an der 1. Med. Abteilung der Krankenanstalt Rudolfstiftung
|
Gender: |
All
|
Age: |
nannan
|
Phases: |
Phase 4
|
Enrollment: |
62
|
Study Type: |
Interventional clinical trial of medicinal product
|
Study Designs: |
Controlled: no<br>Randomised: yes<br>Open: yes<br>Single blind: no<br>Double blind: no<br>Parallel group: yes<br>Cross over: no<br>Other: no<br>If controlled, specify comparator, Other Medicinial Product: no<br>Placebo: no<br>Other: yes<br>Other specify t
|
Start Date: |
24/03/2020
|
Completion Date: |
--
|
Results First Posted: |
--
|
Last Update Posted: |
7 December 2020
|
Locations: |
Austria
|
URL: |
https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000220-19
|